Companies / Beam Therapeutics Inc.

Beam Therapeutics Inc.

Nasdaq: BEAMCIK 1745999CAMBRIDGE, MA

Financials · FY2025

Revenue$139.74M
Net income$-79.99M
Total debt$100.26M
Cash$219.82M
Diluted EPS$-0.81
Shares outstanding103.3M

Ownership

103.3M shares outstanding · as of Jul 28, 2026
1.4%Insiders
Ownership
Insiders1.41%1,458,433
10%+ / strategic17.41%17,978,898
Institutions87.32%90,191,066
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Evans John M.CEOCEO · Director
0.96%986,667
0.18%190,216
Bellon ChristineChief Legal Officer
0.09%95,667
Simon AmyChief Medical Officer
0.07%77,364
Emany Sravan KumarChief Financial Officer
0.07%73,706
Cavanagh Bethany JSVP, Finance and Treasurer
0.03%34,813

Institutional holders 254

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q3 2025
as of
Farallon Capital Management LLC
13F manager
New$244.23M+10.1M
10,063,111
9.74% of shares
high
Q2 2026
as of
State Street Corporation
13F manager
Add$20.54M+599K
+11.45%
5,827,122
5.64% of shares
medium
Q1 2026
as of
Marshall Wace, LLP
13F manager
Trim$-19.22M-807K
-85.28%
139,241
0.13% of shares
medium
Q2 2026
as of
BlackRock, Inc.
13F manager
Add$18.79M+547K
+6.48%
8,997,542
8.71% of shares
medium
Q4 2025
as of
Bank of America Corp /De
13F manager
Trim$-9.75M-352K
-45.15%
427,328
0.41% of shares
medium
Q3 2025
as of
Barclays PLC
13F manager
Trim$-9.00M-371K
-54.19%
313,627
0.30% of shares
medium
Q2 2025
as of
Barclays PLC
13F manager
Add$8.92M+525K
+327.75%
684,599
0.66% of shares
medium
Q1 2026
as of
Renaissance Technologies LLC
13F manager
Add$8.51M+357K
+228.16%
513,578
0.50% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Farallon Capital Partners, L.P.Passive13G/A
ARK Investment Management LLCPassive13G/A
Fmr LLCPassive13G/A12,750,369
State Street CorporationPassive13G5,228,529

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
BEAM07373V105